RONDOL aims to adapt extrusion to the micro scale and to pharmaceutical standards, contributing to more efficient medicines and medical devices, with less side effects and toxicity, greener and cheaper . RONDOL was nominated at the Galien Awards, signed a global technology partnership with SEQENS and a research agreement against child malaria with BASF and QUB. Rondol provides horizontal and vertical extruders that meet the criteria of regulatory agencies.